ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,039 filers reported holding ASTRAZENECA PLC in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,182,195 | +37.8% | 16,509 | +33.5% | 0.04% | +46.4% |
| Q1 2023 | $858,131 | +36.0% | 12,363 | +32.8% | 0.03% | +16.7% |
| Q4 2022 | $631,082 | +4.0% | 9,308 | -44.0% | 0.02% | +20.0% |
| Q3 2022 | $607,000 | -43.3% | 16,636 | +2.4% | 0.02% | -37.5% |
| Q2 2022 | $1,071,000 | -24.8% | 16,252 | -24.4% | 0.03% | -13.5% |
| Q1 2022 | $1,425,000 | +38.8% | 21,485 | +21.9% | 0.04% | +37.0% |
| Q4 2021 | $1,027,000 | -41.2% | 17,622 | -39.5% | 0.03% | -49.1% |
| Q3 2021 | $1,748,000 | +9.9% | 29,107 | +9.7% | 0.05% | +10.4% |
| Q2 2021 | $1,590,000 | +2.2% | 26,541 | -15.2% | 0.05% | -7.7% |
| Q1 2021 | $1,556,000 | -4.8% | 31,290 | -4.3% | 0.05% | -22.4% |
| Q4 2020 | $1,635,000 | +12.5% | 32,700 | +23.3% | 0.07% | -6.9% |
| Q3 2020 | $1,453,000 | +2.0% | 26,514 | -1.5% | 0.07% | -4.0% |
| Q2 2020 | $1,424,000 | +2.8% | 26,923 | -13.2% | 0.08% | -17.6% |
| Q1 2020 | $1,385,000 | -13.9% | 31,014 | -3.8% | 0.09% | -9.0% |
| Q4 2019 | $1,608,000 | +1.0% | 32,246 | -9.7% | 0.10% | -28.1% |
| Q3 2019 | $1,592,000 | +5.9% | 35,713 | -2.0% | 0.14% | +14.9% |
| Q2 2019 | $1,504,000 | -7.8% | 36,430 | -9.7% | 0.12% | +37.5% |
| Q1 2019 | $1,631,000 | +6.3% | 40,330 | -0.2% | 0.09% | +2.3% |
| Q4 2018 | $1,535,000 | -40.6% | 40,416 | -38.1% | 0.09% | -14.9% |
| Q3 2018 | $2,584,000 | +6.5% | 65,307 | -5.5% | 0.10% | +5.2% |
| Q2 2018 | $2,426,000 | +28.4% | 69,090 | +30.5% | 0.10% | +24.7% |
| Q1 2018 | $1,889,000 | +45.2% | 52,953 | +41.2% | 0.08% | +30.5% |
| Q4 2017 | $1,301,000 | +13.0% | 37,505 | +10.4% | 0.06% | -4.8% |
| Q3 2017 | $1,151,000 | +2.5% | 33,983 | +3.1% | 0.06% | -33.3% |
| Q2 2017 | $1,123,000 | +9.3% | 32,954 | -0.1% | 0.09% | -8.8% |
| Q1 2017 | $1,027,000 | +41.1% | 32,986 | +23.7% | 0.10% | +15.9% |
| Q4 2016 | $728,000 | -9.7% | 26,658 | +8.7% | 0.09% | -17.8% |
| Q3 2016 | $806,000 | +8.3% | 24,514 | -0.5% | 0.11% | +1.9% |
| Q2 2016 | $744,000 | -42.0% | 24,637 | -45.9% | 0.10% | +32.9% |
| Q1 2016 | $1,282,000 | +58.7% | 45,534 | +91.3% | 0.08% | -22.5% |
| Q4 2015 | $808,000 | – | 23,807 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |